With the global hair-care market worth more than 98 million dollars in 2019, maybe it's not surprising 10 per cent of cancer patients refuse chemotherapy because of the fear of losing their hair.

My first guest for the 'cancer interview hub' is Rich Paxman, CEO of Paxman Scalp Cooling. With the company's dedication and continuing scientific research, this traumatising side-effect of cancer treatment could become a thing of the past...